Search Results - "Balatoni, Julius A"
-
1
Imaging of HSV-tk Reporter Gene Expression: Comparison Between [18F]FEAU, [18F]FFEAU, and Other Imaging Probes
Published in Journal of Nuclear Medicine (01-04-2008)“…Herpes virus type 1 thymidine kinase (HSV1-tk) and the mutant HSV1-sr39tk are the 2 most widely used "reporter genes" for radiotracer-based imaging. Two…”
Get full text
Journal Article -
2
Radiosynthesis and Initial In Vitro Evaluation of [18F]F-PEG6-IPQA—A Novel PET Radiotracer for Imaging EGFR Expression-Activity in Lung Carcinomas
Published in Molecular imaging and biology (01-10-2011)“…Introduction Epidermal growth factor receptor (EGFR)-targeted therapies with antibodies and small molecular EGFR kinase inhibitors have shown poor efficacy in…”
Get full text
Journal Article -
3
Semi-automated production of 89Zr-oxalate/89Zr-chloride and the potential of 89Zr-chloride in radiopharmaceutical compounding
Published in Applied radiation and isotopes (01-01-2016)“…Interest in using 89Zr is rapidly increasing for immuno-PET applications due to its unique characteristics and increased availability. The focus of this study…”
Get full text
Journal Article -
4
Imaging herpes viral thymidine kinase-1 reporter gene expression with a new 18F-labeled probe: 2′-fluoro-2′-deoxy-5-[ 18F]fluoroethyl-1-β- d-arabinofuranosyl uracil
Published in Nuclear medicine and biology (01-11-2005)“…The preparation and radiolabeling of 2′-fluoro-2′-deoxy-1-β- d-arabinofuranosyl-5-(2-fluoroethyl)-uracil (FFEAU) with 18F and its evaluation as a probe for…”
Get full text
Journal Article -
5
Semi-automated production of 89 Zr-oxalate/ 89 Zr-chloride and the potential of 89 Zr-chloride in radiopharmaceutical compounding
Published in Applied radiation and isotopes (01-01-2016)Get full text
Journal Article -
6
Radiosynthesis and Initial In Vitro Evaluation of [^sup 18^F]F-PEG^sub 6^-IPQA--A Novel PET Radiotracer for Imaging EGFR Expression-Activity in Lung Carcinomas
Published in Molecular imaging and biology (01-10-2011)“…Epidermal growth factor receptor (EGFR)-targeted therapies with antibodies and small molecular EGFR kinase inhibitors have shown poor efficacy in unselected…”
Get full text
Journal Article